Navigation Links
ResMed Announces Conference Call And Webcast To Discuss Second Quarter 2014 Results
Date:12/18/2013

SAN DIEGO, Dec. 18, 2013 /PRNewswire/ -- RESMED INC. (NYSE: RMD) announced today that on Thursday, January 23, 2014, it will release its results for the second quarter and six months of fiscal year 2014, ended December 31, 2013. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

The conference call is scheduled to begin at 1:30 p.m. US Pacific Time and will be webcast on ResMed's website at http://investor.resmed.com.  Please go to this section of the website 5-10 minutes before the call and click on the icon for the "Q2 2014 results webcast." The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be:9:30 p.m. 

London8:30 a.m. 

Sydney, Australia (January 24, 2014)TO PARTICIPATE in the conference call, please call one of the numbers below at least 10 minutes before the call begins and identify yourself to the operator:

US:

847-585-4405 Outside US:

+1 847-585-4405Conference Name:

Q2 2014 ResMed Inc. Results Conference Call Participant Passcode:

36303553The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:

US:630- 652-3042Outside US:+1 630-652-3042Passcode:36303553ResMed is a global leader in the development, manufacturing, and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.

Further information can be obtained by contacting Constance Bienfait at ResMed Inc. at +1 (858) 836-5971, or by visiting the company's website at www.resmed.com.


'/>"/>
SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BMC to protect its rights in patent fight with ResMed
2. Apex reagiert energisch auf ResMed Patentklage
3. ResMed Receives Injunctions against APEX and BMC in Germany, Continues Enforcement of Patents in Europe
4. ResMed Inc. Announces Record Financial Results For The Quarter Ended September 30, 2013
5. ResMeds New Nasal Mask Sets the Bar for Comfort and Performance
6. ResMed Patent Infringement Case Against BMC Advances: International Trade Commission Agrees to Investigate
7. Apex Fights Back Against ResMeds Patent Litigation
8. ResMed Takes New Action to Enforce Patents
9. ResMed Succeeds in Patent Fight Against APEX
10. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
11. FDA Approvals, Diversified Product Pipeline, Produce Sales Growth, and Positive Study Outcomes - Research Report on Boston Scientific, Zimmer, St. Jude, ResMed, and GenMark
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Oct. 12, 2017 AVACEN Medical , Inc. ... with their  2017 New Product Innovation Award for Its ... primary and secondary medical device market research by Frost & ... first-to-market OTC, drug-free pain relief product, the AVACEN 100, offers ... treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):